The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks gestation
Carmel Collins, Robert Gibson, Maria Makrides, Andrew McPhee, Thomas Sullivan, Peter Davis, Marta Tio, Karen Simmer, V Rajadurai, Scott Morris
Research output: Contribution to journal › Article › peer-review
26Citations
(Scopus)
Fingerprint
Dive into the research topics of 'The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks gestation'. Together they form a unique fingerprint.